178 related articles for article (PubMed ID: 36749458)
1. Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
Allman R; Mu Y; Dite GS; Spaeth E; Hopper JL; Rosner BA
Breast Cancer Res Treat; 2023 Apr; 198(2):335-347. PubMed ID: 36749458
[TBL] [Abstract][Full Text] [Related]
2. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
3. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
[TBL] [Abstract][Full Text] [Related]
4. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
[TBL] [Abstract][Full Text] [Related]
6. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
7. Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation.
Rosner B; Tamimi RM; Kraft P; Gao C; Mu Y; Scott C; Winham SJ; Vachon CM; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):600-607. PubMed ID: 33277321
[TBL] [Abstract][Full Text] [Related]
8. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
[TBL] [Abstract][Full Text] [Related]
9. Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors.
Palomares MR; Machia JR; Lehman CD; Daling JR; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1324-30. PubMed ID: 16835331
[TBL] [Abstract][Full Text] [Related]
10. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
[TBL] [Abstract][Full Text] [Related]
12. Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study.
Rosner BA; Colditz GA; Hankinson SE; Sullivan-Halley J; Lacey JV; Bernstein L
Breast Cancer Res Treat; 2013 Nov; 142(1):187-202. PubMed ID: 24158759
[TBL] [Abstract][Full Text] [Related]
13. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.
Tice JA; Cummings SR; Ziv E; Kerlikowske K
Breast Cancer Res Treat; 2005 Nov; 94(2):115-22. PubMed ID: 16261410
[TBL] [Abstract][Full Text] [Related]
14. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
[TBL] [Abstract][Full Text] [Related]
15. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
[TBL] [Abstract][Full Text] [Related]
16. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
17. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
[TBL] [Abstract][Full Text] [Related]
18. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
[TBL] [Abstract][Full Text] [Related]
19. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.
Wang X; Huang Y; Li L; Dai H; Song F; Chen K
Breast Cancer Res; 2018 Mar; 20(1):18. PubMed ID: 29534738
[TBL] [Abstract][Full Text] [Related]
20. Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction.
Lee CP; Choi H; Soo KC; Tan MH; Chay WY; Chia KS; Liu J; Li J; Hartman M
PLoS One; 2015; 10(9):e0136650. PubMed ID: 26401662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
